Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis

Muscle and Nerve

Volumn 36, Issue 1, 2007, Pages 100-103

  Utsugisawa, Kimiaki ^a   Nagane, Yuriko ^a   Suzuki, Shigeaki ^b   Kondoh, Ryushi ^c  

^a Hanamaki General Hospital   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Dendritic cell; Myasthenia gravis; Protein kinase C ; T cell activation; Thymus

Indexed keywords

CD83 ANTIGEN; HERMES ANTIGEN; PROTEIN KINASE C THETA;

ADOLESCENT; ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; THYMECTOMY; THYMUS HYPERPLASIA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD44; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYASTHENIA GRAVIS; PROTEIN KINASE C; T-LYMPHOCYTES; THYMECTOMY; THYMUS HYPERPLASIA;

EID: 34347356502     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20794     Document Type: Article

References (14)

1. Altman A, Isakov N, Baier G. Protein kinase C θ: a new essential superstar on the T-cell stage. Immunol Today 2000; 21:567-573.
2. Bofill M, Janossy G, Willcox N, Chilosi M, Trejdosiewicz LK, Newsom-Davis J. Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am J Pathol 1985;119: 462-473.
3. Fujii Y, Lindstrom J. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis. J Immunol 1988;141:3361-3369.
4. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:7-15.
5. Kissel JT, Franklin GM, and the Quality Standards Subcommittee of the American Academy of Neurology. Treatment of myasthenia gravis - a call to arms. Neurology 2000;55:3-4.
6. Liu Y, Graham C, Li A, Fisher RJ, Shaw S. Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-κB induction. Biochem J 2002;361:255-265.
7. Marx A, Wilisch A, Schultz A, Gattenlöhner S, Nenninger R, Müller-Hermelink HK. Pathogenesis of myasthenia gravis. Virchows Arch 1997;430:355-364.
8. Nagane Y, Utsugisawa K, Obara D, Yamagata M, Tohgi H. Dendritic cells in hyperplastic thymuses from patents with myasthenia gravis. Muscle Nerve 2003;27:582-589.
9. Nagane Y, Utsugisawa K, Akutsu H, Sato Y, Terayama Y. Perivascular infiltrate of memory lymphocytes and mature dendritic cells in MG thymomas. Neurology 2005;65:770-772.
10. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Science 1973;180:871-872.
11. Shiono H, Roxanis I, Zhang W, Sims GP, Meager A, Jacobson LW, et al. Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann N Y Acad Sci 2003;998:237-256.
12. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America: Jaretzki A III, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55: 16-23.
13. Utsugisawa K, Nagane Y, Tohgi H. Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with myasthenia gravis. Muscle Nerve 2000;23:507-513.
14. Vincent A, Willcox N, Hill M, Curnow J, MacLennan C, Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998;164:157-168.